MedPath

Effect of nyagrodhadi churna and b-s patra ghana vati in diabetic patients.

Phase 1
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2019/04/018729
Lead Sponsor
Rishikul campus
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

fasting blood glucose level > 110mg/dl-250mg/dl

post Prandial blood sugar level > 140 mg/dl-350mg/dl

Exclusion Criteria

patients of type 1 diabetes mellitus

fasting blood glucose level > 250 mg/dl

post prandial blood glucose level > 350 mg/dl

patients having complication

other serious medical & surgical ill patient

patient cannot follow the dietary regime

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
o assess the effect of therapy, objectively all signs and symptoms were given scoring depending upon their severity <br/ ><br>No improvement- 25% improvement <br/ ><br>Mild improvement- 25% to 50% <br/ ><br>Moderate improvement-50% to 75% improvement <br/ ><br>Marked improvement- 75% improvement <br/ ><br>Complete improvement-100% improvementTTimepoint: Duration of study- 60 days
Secondary Outcome Measures
NameTimeMethod
to assess the effect of therapy, objectively all signs and symptoms were given scoring depending upon their severity <br/ ><br>No improvement- 25% improvement <br/ ><br>Mild improvement- 25% to 50% <br/ ><br>Moderate improvement-50% to 75% improvement <br/ ><br>Marked improvement- 75% improvement <br/ ><br>Complete improvement-100% improvementTimepoint: Duration of study- 60 days
© Copyright 2025. All Rights Reserved by MedPath